Angola remains among the 30 countries globally with the highest rates of tuberculosis (TB), a persistent public health challenge despite a general downward trend in cases. New data reveals a concerning rise in patients discontinuing treatment, complicating efforts to control the disease. In 2025, over 85,000 people in Angola were infected with tuberculosis and tragically, 657 died from the illness, according to Damião Victoriano, the coordinator of the National Tuberculosis Control Program.
The situation is particularly acute in the provinces of Bengo, Benguela, and Namibe, which are currently reporting the highest number of TB cases nationwide. This concentration of illness underscores regional disparities in access to healthcare, socioeconomic factors, and potentially, the effectiveness of local control programs. Understanding these localized factors is crucial for tailoring interventions and maximizing impact.
A significant obstacle to progress is the growing number of patients who are abandoning their TB treatment regimens. In 2025 alone, 6,815 individuals stopped taking their medication, a figure that raises serious concerns about the potential for drug-resistant strains of TB to emerge and spread. Treatment interruption not only jeopardizes the health of the individual but likewise contributes to the ongoing transmission of the disease within communities.
Understanding the Challenges to TB Control in Angola
Tuberculosis is an infectious disease typically caused by the bacterium Mycobacterium tuberculosis, which primarily affects the lungs. It’s spread through the air when people with active TB cough, sneeze, or otherwise transmit respiratory fluids. While preventable and curable with a course of antibiotics, TB thrives in conditions of poverty, overcrowding, and malnutrition – factors that unfortunately remain prevalent in many parts of Angola. The World Health Organization (WHO) provides comprehensive information on tuberculosis, its transmission, and global efforts to combat the disease.
The reasons behind treatment abandonment are complex and multifaceted. They can include financial hardship, making it difficult to afford transportation to clinics or take time off operate. Stigma associated with TB can also deter individuals from seeking or continuing treatment. Side effects from the medication, while usually manageable, can sometimes be severe enough to cause patients to discontinue their regimens without consulting a healthcare professional. A lack of consistent follow-up and support from healthcare providers can contribute to patients falling through the cracks.
Regional Disparities and the Impact on Bengo, Benguela, and Namibe
The concentration of TB cases in Bengo, Benguela, and Namibe provinces warrants further investigation. These provinces may face unique challenges related to healthcare infrastructure, access to diagnostic services, and the prevalence of risk factors such as HIV co-infection. USAID’s work in tuberculosis control highlights the importance of addressing social determinants of health and strengthening health systems to effectively combat the disease.
Understanding the specific context within each province is essential for developing targeted interventions. For example, in coastal provinces like Namibe, factors such as fishing communities and migratory patterns may play a role in disease transmission. In Benguela, a major urban center, overcrowding and limited access to sanitation could contribute to the spread of TB. Bengo, with its proximity to the capital Luanda, may experience challenges related to population movement and access to specialized care.
Efforts to Combat Tuberculosis and Improve Treatment Adherence
The National Tuberculosis Control Program in Angola is working to address these challenges through a variety of strategies. These include strengthening diagnostic capacity, ensuring access to quality treatment, and implementing programs to support patients throughout their treatment journey. Efforts are also underway to raise awareness about TB and reduce the stigma associated with the disease.
Improving treatment adherence is a key priority. This involves providing patients with financial assistance to cover transportation and other costs, offering counseling and support to address psychosocial barriers, and implementing directly observed therapy (DOT), where healthcare workers directly supervise patients taking their medication. Innovative approaches, such as mobile health (mHealth) technologies, are also being explored to improve communication and provide remote support to patients.
Collaboration between the government, international organizations, and local communities is crucial for success. Stop TB Partnership is a global network of organizations working to conclude tuberculosis, and provides resources and advocacy support to countries like Angola.
The rise in treatment abandonment is a worrying trend, but one that can be addressed with sustained investment, targeted interventions, and a commitment to patient-centered care. Continued monitoring of epidemiological data, coupled with rigorous evaluation of program effectiveness, will be essential for guiding future efforts.
Disclaimer: This article provides information for general knowledge and informational purposes only, and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
The next update on Angola’s tuberculosis control efforts is expected to be released by the National Tuberculosis Control Program in the fourth quarter of 2026. We encourage readers to share their thoughts and experiences in the comments below.
